Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Anturol Gel has a promising pharmacokinetic and safety profile in healthy volunteers

July 18, 2008

Topical PSD-503 safe and effective for the treatment of stress urinary incontinence

July 17, 2008

Recent Aska patent describes novel agents for urinary disorders

July 11, 2008

Light Sciences Oncology begins clinical trials of Litx therapy in patients with BPH

July 9, 2008

Pfizer launches Toviaz once-daily treatment for the symptoms of overactive bladder

July 3, 2008

Action starts phase II trial with AP-214 for organ failure associated with surgery

July 1, 2008

FDA Advisory Committee recommends approval of tolvaptan

June 26, 2008

Nymox presents new data for NX-1207 in benign prostatic hyperplasia

June 26, 2008

FDA approves Avodart in combination with tamsulosin for enlarged prostate

June 23, 2008

Nymox commences phase III NX-1207 program

June 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...